Showing results (741-750 of 3,565) with videos related to
Sort By:
Pageof 357
Journal of Thrombosis and Thrombolysis|April 5, 2019
Evaluation of weight based enoxaparin dosing on anti-Xa concentrations in patients with obesityNameer van Oosterom, Karl Winckel, Michael BarrasJournal of Thrombosis and Thrombolysis|July 22, 2019
MINOCA presenting with STEMI: incidence, aetiology and outcome in a contemporaneous cohortYing X Gue, Natasha Corballis, Alisdair Ryding, et al.Journal of Thrombosis and Thrombolysis|April 8, 2019
Clinical experience of idarucizumab use in cases of cardiac tamponade under uninterrupted anticoagulation of dabigatran during catheter ablation of atrial fibrillationKaoru Okishige, Yasuteru Yamauchi, Yuichi Hanaki, et al.Journal of Thrombosis and Thrombolysis|July 19, 2019
Description of anti-Xa monitoring practices during low molecular weight heparin useAlbert Lin, Sara R Vazquez, Aubrey E Jones, et al.Journal of Thrombosis and Thrombolysis|February 1, 2017
Trends in oral anticoagulant use in Qatar: a 5-year experienceHazem Elewa, Amani Alhaddad, Safa Al-Rawi, et al.Journal of Thrombosis and Thrombolysis|October 31, 2018
Carbon monoxide inhibits the anticoagulant activity of phospholipase A2 purified from Crotalus adamanteus venomVance G NielsenJournal of Thrombosis and Thrombolysis|November 23, 2018
Combination index of the concentration and in vivo antagonism activity of racemic warfarin and its metabolites to assess individual drug responsesShuhei Kobayashi, Koji Ishii, Yasuko Yamada, et al.Journal of Thrombosis and Thrombolysis|January 31, 2014
Estimation of the impact of warfarin's time-in-therapeutic range on stroke and major bleeding rates and its influence on the medical cost avoidance associated with novel oral anticoagulant use-learnings from ARISTOTLE, ROCKET-AF, and RE-LY trialsAlpesh Amin, Steve Deitelzweig, Yonghua Jing, et al.Journal of Thrombosis and Thrombolysis|June 3, 2008
Indications of combined vitamin K antagonists and aspirin therapyA Loualidi, S H J Bredie, M C H JanssenJournal of Thrombosis and Thrombolysis|May 20, 2008
The clinical diagnosis of heparin-induced thrombocytopenia in patients receiving continuous renal replacement therapyChris E Holmes, Joe C Huang, Carina Cartelli, et al.Pageof 357